KIDRON NADAV (President and CEO) received a stock award from ORAMED PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 1/5/2026ACC: 0001213900-26-001280
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
+668.64K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
668.64K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+232.64K
Price / share
—
Trade value
—
% of position
8.7%
12/31/2025
2.69M→2.92M
Common Stock
Direct
Shares
+327K
Price / share
—
Trade value
—
% of position
11.2%
12/31/2025
2.92M→3.25M
Total
Net shares
+559.64K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2025 | A · Award | +232.64K | — | — | 8.7% | 2.69M | 2.92M |
| Common Stock Direct | 12/31/2025 | A · Award | +327K | — | — | 11.2% | 2.92M | 3.25M |
| Total | +559.64K | $0.00 | ||||||
Derivative Transactions1
Performance Stock Units
Direct
Converts to
Common Stock
109K shares
Shares
+109K
Strike price
Held after
109K
Exercisable
—
12/31/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Stock Units Direct | Common Stock109K shares | 12/31/2025 | A · Award | +109K | — | 109K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned126K
Total
126K indirect126K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 126K | Indirect |
| Total | 126K | 126K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported